Putra Ramendra Dirgantara, Lyrawati Diana
Department of Pharmacy, Faculty of Medicine, Brawijaya University, Malang 65145, Indonesia.
Scientifica (Cairo). 2020 Jun 9;2020:3589316. doi: 10.1155/2020/3589316. eCollection 2020.
As the name implies, bacteriophage is a bacterium-specific virus. It infects and kills the bacterial host. Bacteriophages have gained attention as alternative antimicrobial entities in the science community in the western world since the alarming rise of antibiotic resistance among microbes. Although generally considered as prokaryote-specific viruses, recent studies indicate that bacteriophages can interact with eukaryotic organisms, including humans. In the current review, these interactions are divided into two categories, i.e., indirect and direct interactions, with the involvement of bacteriophages, bacteria, and eukaryotes. We discuss bacteriophage-related diseases, transcytosis of bacteriophages, bacteriophage interactions with cancer cells, collaboration of bacteriophages and eukaryotes against bacterial infections, and horizontal gene transfer between bacteriophages and eukaryotes. Such interactions are crucial for understanding and developing bacteriophages as the therapeutic agents and pharmaceutical delivery systems. With the advancement and combination of in silico, , and approaches and clinical trials, bacteriophages definitely serve as useful repertoire for biologic target-based drug development to manage many complex diseases in the future.
顾名思义,噬菌体是一种专门感染细菌的病毒。它感染并杀死细菌宿主。自从微生物中抗生素耐药性惊人地上升以来,噬菌体作为替代抗菌实体在西方科学界受到了关注。尽管通常被认为是原核生物特有的病毒,但最近的研究表明,噬菌体可以与包括人类在内的真核生物相互作用。在当前的综述中,这些相互作用分为两类,即间接相互作用和直接相互作用,涉及噬菌体、细菌和真核生物。我们讨论了与噬菌体相关的疾病、噬菌体的转胞吞作用、噬菌体与癌细胞的相互作用、噬菌体与真核生物对抗细菌感染的协作,以及噬菌体与真核生物之间的水平基因转移。此类相互作用对于理解和开发噬菌体作为治疗剂和药物递送系统至关重要。随着计算机模拟、[此处原文缺失部分内容]和[此处原文缺失部分内容]方法以及临床试验的进步与结合,噬菌体肯定会成为基于生物靶点的药物开发的有用资源,以在未来治疗许多复杂疾病。